Pulmonx (LUNG) Operating Income (2019 - 2025)
Pulmonx (LUNG) posted quarterly Operating Income of -$14.4 million for Q3 2025, down 1.87% year-over-year from -$14.7 million in Q3 2024, and up 2.78% quarter-over-quarter from -$14.8 million in Q2 2025.
Pulmonx (LUNG) Operating Income (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Operating Income for 7 consecutive years, with -$14.4 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Operating Income fell 1.87% year-over-year to -$14.4 million; the TTM figure through Sep 2025 stood at -$57.2 million (up 1.77% YoY), while the FY2024 annual figure was -$57.7 million, up 6.83% from the prior year.
- Operating Income advanced to -$14.4 million in Q3 2025 per LUNG's latest filing, from -$14.8 million in the prior quarter.
- Across five years, Operating Income topped out at -$9.8 million in Q3 2021 and bottomed at -$16.4 million in Q2 2023.
- Historically, Operating Income has averaged -$14.2 million across 5 years, with a median of -$14.4 million in 2022.
- Annual changes were most pronounced in 2021 — Operating Income plunged 104.69% — and 2024, when it advanced 11.37%.
- Pulmonx's Operating Income stood at -$12.4 million in 2021, then declined by 18.28% to -$14.6 million in 2022, then advanced by 4.84% to -$13.9 million in 2023, then gained by 3.61% to -$13.4 million in 2024, then retreated by 7.27% to -$14.4 million in 2025.
- Business Quant data shows LUNG's Operating Income at -$14.4 million in Q3 2025, -$14.8 million in Q2 2025, and -$14.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Pulmonx | 97.63 Mn | 27.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -14.39 Mn |
| Jun 30, 2025 | -14.80 Mn |
| Mar 31, 2025 | -14.56 Mn |
| Dec 31, 2024 | -13.42 Mn |
| Sep 30, 2024 | -14.13 Mn |
| Jun 30, 2024 | -15.62 Mn |
| Mar 31, 2024 | -14.54 Mn |
| Dec 31, 2023 | -13.92 Mn |
| Sep 30, 2023 | -15.18 Mn |
| Jun 30, 2023 | -16.44 Mn |
| Mar 31, 2023 | -16.40 Mn |
| Dec 31, 2022 | -14.63 Mn |
| Sep 30, 2022 | -13.93 Mn |
| Jun 30, 2022 | -14.41 Mn |
| Mar 31, 2022 | -15.67 Mn |
| Dec 31, 2021 | -12.37 Mn |
| Sep 30, 2021 | -9.76 Mn |
| Jun 30, 2021 | -12.68 Mn |
| Mar 31, 2021 | -12.49 Mn |
| Dec 31, 2020 | -9.35 Mn |